5-Nitro-2-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)benzonitrile

ID: ALA4092657

Chembl Id: CHEMBL4092657

PubChem CID: 137656039

Max Phase: Preclinical

Molecular Formula: C14H9N5O3

Molecular Weight: 295.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1cc([N+](=O)[O-])ccc1Nc1ccc2[nH]c(=O)[nH]c2c1

Standard InChI:  InChI=1S/C14H9N5O3/c15-7-8-5-10(19(21)22)2-4-11(8)16-9-1-3-12-13(6-9)18-14(20)17-12/h1-6,16H,(H2,17,18,20)

Standard InChI Key:  NJXVPYSOGLBERP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4092657

    ---

Associated Targets(Human)

BCL6 Tchem BCoR-BCL6 (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 295.26Molecular Weight (Monoisotopic): 295.0705AlogP: 2.38#Rotatable Bonds: 3
Polar Surface Area: 127.61Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.88CX Basic pKa: CX LogP: 2.38CX LogD: 2.38
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.50Np Likeness Score: -1.99

References

1. Yasui T, Yamamoto T, Sakai N, Asano K, Takai T, Yoshitomi Y, Davis M, Takagi T, Sakamoto K, Sogabe S, Kamada Y, Lane W, Snell G, Iwata M, Goto M, Inooka H, Sakamoto JI, Nakada Y, Imaeda Y..  (2017)  Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.,  25  (17): [PMID:28760529] [10.1016/j.bmc.2017.07.037]

Source